EFFECTIVENESS OF BARICITINIB IN THE BASIC THERAPY OF ACTIVE RHEUMATOID ARTHRITIS

The purpose of our study was to evaluate the efficacy and safety of baricitinib (BARI) in patients with rheumatoid arthritis (RA) who have not achieved low activity or remission according to EULAR criteria under the influence of synthetic disease-modifying drugs or biological agents.

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2025-03-04
DOI: https://doi.org/10.5281/zenodo.14964694
Primary Topic: Rheumatoid Arthritis Research and Therapies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

EFFECTIVENESS OF BARICITINIB IN THE BASIC THERAPY OF ACTIVE RHEUMATOID ARTHRITIS

Mar 4, 2025

Zenodo (CERN European Organization for Nuclear Research)

Rheumatoid Arthritis Research and Therapies

article

EFFECTIVENESS OF BARICITINIB IN THE BASIC THERAPY OF ACTIVE RHEUMATOID ARTHRITIS

March 4, 2025article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Good health and well-being

Openalex Percentile: Top 41%

Rheumatoid Arthritis Research and Therapies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EFFECTIVENESS OF BARICITINIB IN THE BASIC THERAPY OF ACTIVE RHEUMATOID ARTHRITIS · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS